Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001376571.1(MADD):āc.2251G>Cā(p.Val751Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
MADD (HGNC:6766): (MAP kinase activating death domain) Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);Gain of catalytic residue at V751 (P = 0.0592);